Display options
Share it on

Hematol Rep. 2012 Nov 19;4(4):e20. doi: 10.4081/hr.2012.e20.

Deep vein thrombosis, ecythyma gangrenosum and heparin-induced thrombocytopenia occurring in a man with a heterozygous Factor V Leiden mutation.

Hematology reports

Mariya Apostolova, Baoying Weng, Harry H Pote, Harold Ashcraft, Curtis Goldblatt, Paul V Woolley

Affiliations

  1. Department of Medicine, Department of Pathology and Conemaugh Cancer Care Center, Conemaugh Memorial Medical Center, Johnstown, PA, USA.

PMID: 23355938 PMCID: PMC3555208 DOI: 10.4081/hr.2012.e20

Abstract

Skin necrosis and limb gangrene are occasional thrombotic manifestations of anticoagulation therapy. We report a man heterozygous for the Factor V Leiden (FVL) mutation, and with a history of recurrent deep venous thrombosis, who initially presented with a necrotic skin lesion of the right flank while on warfarin therapy with a therapeutic international normalized ratio. Warfarin was discontinued and he received intravenous heparin. Thereafter he developed thrombocytopenia and pedal erythema and was diagnosed with heparin-induced thrombocytopenia (HIT). Heparin was replaced with argatroban. He ultimately underwent bilateral below-knee amputations for the thrombotic complications of the HIT. The initial necrotic lesion healed with antibiotics and wound care. Pathologic examination of multiple biopsy specimens revealed two separate lesions. One was necrotic tissue infiltrated with methicillin resistant Staphylococcus aureus having features of ecthyma gangrenosum. The second showed thrombotic changes consistent with HIT. The case illustrates the differential diagnosis of skin necrosis and limb gangrene in patients on warfarin and heparin, and also the clinical complexities that can occur in a FVL heterozygote.

Keywords: Factor V Leiden; deep vein thrombosis.; ecthyma gangrenosum; heparin induced thrombocytopenia

References

  1. J Am Acad Dermatol. 2009 Aug;61(2):325-32 - PubMed
  2. Arch Fam Med. 1992 Sep;1(1):105-8 - PubMed
  3. Rheumatology (Oxford). 2009 Aug;48(8):1003-7 - PubMed
  4. J Med Case Rep. 2008 Jan 22;2:14 - PubMed
  5. An Bras Dermatol. 2010 Nov-Dec;85(6):915-8 - PubMed
  6. Am J Health Syst Pharm. 2008 Jun 15;65(12):1144-7 - PubMed
  7. Interact Cardiovasc Thorac Surg. 2010 Jul;11(1):127-9 - PubMed
  8. Indian J Dermatol Venereol Leprol. 2005 Mar-Apr;71(2):128-9 - PubMed
  9. J Pediatr Surg. 2009 Aug;44(8):1640-2 - PubMed
  10. J Emerg Med. 2012 Aug;43(2):e133-4 - PubMed
  11. Hematology Am Soc Hematol Educ Program. 2006;:408-14 - PubMed
  12. Cutis. 2009 Nov;84(5):261-7 - PubMed
  13. Interact Cardiovasc Thorac Surg. 2009 Dec;9(6):1023-5 - PubMed
  14. Acta Haematol. 2008;120(2):117-22 - PubMed
  15. J Thromb Haemost. 2003 Jul;1(7):1471-8 - PubMed
  16. Am J Hematol. 1998 Mar;57(3):233-7 - PubMed
  17. Int J Infect Dis. 2009 Jul;13(4):e173-5 - PubMed
  18. J Vasc Surg. 1997 Feb;25(2):271-5; discussion 276 - PubMed
  19. Thromb J. 2005 Oct 04;3:14 - PubMed

Publication Types